Crinetics Pharmaceuticals CRNX License — Milestone revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept crnx:MilestoneRevenue.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's license — milestone revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's license — milestone revenue?
- Crinetics Pharmaceuticals (CRNX) reported license — milestone revenue of $1.5M in Q2 2026.
- What does license — milestone revenue mean?
- Revenue recognized upon the successful achievement of specific, contractually defined events such as regulatory approvals or clinical trial results. This metric tracks the realization of variable consideration within licensing agreements. It is a vital indicator of the company's ability to successfully advance its pipeline and convert research progress into financial results.